Smith & Nephew plc (FRA:NPW1)

Germany flag Germany · Delayed Price · Currency is EUR
14.18
+0.09 (0.67%)
At close: Dec 4, 2025
17.53%
Market Cap 12.28B
Revenue (ttm) 5.07B
Net Income (ttm) 419.07M
Shares Out n/a
EPS (ttm) 0.48
PE Ratio 29.31
Forward PE 15.64
Dividend 0.34 (2.39%)
Ex-Dividend Date Oct 2, 2025
Volume n/a
Average Volume n/a
Open 14.18
Previous Close 14.09
Day's Range 14.18 - 14.18
52-Week Range 11.25 - 16.64
Beta n/a
RSI 40.35
Earnings Date Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1856
Employees 17,349
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol NPW1
Full Company Profile

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD Financial Statements

News

There is no news available yet.